Scientists in the US developed a blood test with four biomarkers for early pancreatic cancer detection The test showed 91% accuracy and 87% sensitivity for early-stage pancreatic cancer diagnosis It can distinguish pancreatic cancer from benign pancreatic diseases with a low false-positive rate
